keyword
https://read.qxmd.com/read/38515121/sepsis-associated-acute-kidney-injury-recent-advances-in-enrichment-strategies-sub-phenotyping-and-clinical-trials
#21
REVIEW
Matthieu Legrand, Sean M Bagshaw, Pavan K Bhatraju, Azra Bihorac, Ellen Caniglia, Ashish K Khanna, John A Kellum, Jay Koyner, Michael O Harhay, Fernando G Zampieri, Alexander Zarbock, Kevin Chung, Kathleen Liu, Ravindra Mehta, Peter Pickkers, Abigail Ryan, Juliane Bernholz, Laura Dember, Martin Gallagher, Patrick Rossignol, Marlies Ostermann
Acute kidney injury (AKI) often complicates sepsis and is associated with high morbidity and mortality. In recent years, several important clinical trials have improved our understanding of sepsis-associated AKI (SA-AKI) and impacted clinical care. Advances in sub-phenotyping of sepsis and AKI and clinical trial design offer unprecedented opportunities to fill gaps in knowledge and generate better evidence for improving the outcome of critically ill patients with SA-AKI. In this manuscript, we review the recent literature of clinical trials in sepsis with focus on studies that explore SA-AKI as a primary or secondary outcome...
March 21, 2024: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/38510059/the-homeside-study-a-research-project-to-support-people-living-with-dementia-and-their-family-caregivers-preliminary-report-on-reading-intervention
#22
JOURNAL ARTICLE
Agnieszka Smrokowska-Reichmann, Edyta Janus, Jeanette Tamplin, Helen Odell-Miller, Karette Stensæth, Jennifer Wenborn, Rønnaug Modell Viken, Thomas Wosch, Anna A Bukowska, Tanara Vieira Sousa, Felicity Anne Baker
The behavioral and psychological symptoms of dementia (BPSD) can be challenging for family caregivers to cope with, leading to distress and fatigue. It is therefore important to offer effective strategies to reduce the impact of BPSD. The HOMESIDE randomized controlled trial (RCT) was testing purposefully developed interventions to improve the quality of life and wellbeing of dyads of people with dementia and family caregivers as a result of reduction of BPSD. HOMESIDE RCT was conducted in Australia, Germany, Norway, Poland and the United Kingdom between 2019 and 2022...
2024: Gerontology & Geriatric Medicine
https://read.qxmd.com/read/38500753/computed-tomographic-angiography-measures-of-coronary-plaque-in-clinical-trials-opportunities-and-considerations-to-accelerate-drug-translation
#23
REVIEW
N Howden, K Branch, P Douglas, M Gray, M Budoff, M Dewey, D E Newby, S J Nicholls, R Blankstein, S Fathieh, S M Grieve, G A Figtree
Atherosclerotic coronary artery disease (CAD) is the causal pathological process driving most major adverse cardiovascular events (MACE) worldwide. The complex development of atherosclerosis manifests as intimal plaque which occurs in the presence or absence of traditional risk factors. There are numerous effective medications for modifying CAD but new pharmacologic therapies require increasingly large and expensive cardiovascular outcome trials to assess their potential impact on MACE and to obtain regulatory approval...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38496882/clinical-efficacy-and-potential-mechanism-of-ginseng-polysaccharides-in-the-treatment-of-non-small-cell-lung-cancer-based-on-meta-analysis-associated-with-network-pharmacology
#24
JOURNAL ARTICLE
Qi Zhao, Le Bai, Dongwei Zhu, Tingyuan Li, Jie Xu, Yong Xu, Xianmei Zhou
BACKGROUND: The ginseng polysaccharide injection is a well-known traditional Chinese medicine often employed as a supplementary treatment for cancer. This treatment can not only alleviate the adverse effects caused by tumor radiotherapy and chemotherapy but also enhance the immune system of individuals diagnosed with lung cancer. It is important to acknowledge the efficacy of ginseng polysaccharide injection in the treatment of non-small cell lung cancer (NSCLC). However, these small-sample studies may have certain biases, and the underlying mechanisms of ginseng polysaccharides therapy for NSCLC are still unclear...
March 30, 2024: Heliyon
https://read.qxmd.com/read/38485475/effectiveness-of-a-community-based-multicomponent-lifestyle-intervention-the-ada-programme-to-improve-the-quality-of-life-of-french-breast-cancer-survivors-protocol-for-a-pragmatic-cluster-randomised-trial-and-embedded-qualitative-study
#25
JOURNAL ARTICLE
Fabienne El-Khoury, Jean-Christophe Mino, Nicolas Deschamps, Chloé Lopez, Gwenn Menvielle, Patricia Dargent-Molina
INTRODUCTION: Breast cancer survivors (BCSs) are often faced with multiple mental and physical sequelae and are at increased risk of emotional distress, degraded health-related quality of life (HRQoL), chronic pain and fatigue.Physical activity is strongly associated with improved HRQoL and survival rates; however, adherence rates to recommendations for a healthy lifestyle are seldom satisfactory among BCSs. Also, few studies have examined the effectiveness of multicomponent and personalised interventions that integrate physical activity and motivational techniques to improve the HRQoL of BCS...
March 14, 2024: BMJ Open
https://read.qxmd.com/read/38481512/targeting-gut-microbiome-with-prebiotic-in-patients-with-ckd-the-targut-ckd-study
#26
JOURNAL ARTICLE
Michael B Sohn, Bei Gao, Cynthia Kendrick, Anvesha Srivastava, Tamara Isakova, Jennifer J Gassman, Linda F Fried, Myles Wolf, Alfred K Cheung, Kalani L Raphael, Patricia Centron Vinales, John P Middleton, Ana Pabalan, Dominic S Raj
INTRODUCTION: Disruption of gut microbiota underpins some of the metabolic alterations observed in chronic kidney disease (CKD). METHODS: In a nonrandomized, open-label, 3-phase pilot trial, with repeated measures within each phase, we examined the efficacy of oligofructose-enriched inulin (p-inulin) in changing the gut microbiome and their metabolic products in 15 patients with CKD. The stability of microbiome and metabolome was studied during the pretreatment phase (8 weeks), a p-inulin treatment phase (12 weeks), and a post treatment phase (8 weeks) of the study...
March 2024: KI Reports
https://read.qxmd.com/read/38478332/cancer-stem-cells-current-challenges-and-future-perspectives
#27
REVIEW
Muhammad Vaseem Shaikh, Stefan Custers, Alisha Anand, Petar Miletic, Chitra Venugopal, Sheila K Singh
Despite major advances in health care including improved diagnostic tools, robust chemotherapeutic regimens, advent of precision, adjuvant and multimodal therapies, there is a major proportion of patients that still go on to experience tumor progression and recurrence. Cancer stem cells (CSCs) are shown to be responsible for tumor persistence and relapse. This subpopulation of cancer cells possess normal stem cell like traits of self-renewal, proliferation, and multilineage differentiation. Currently, they are isolated and enriched based on the cell surface markers that can be detected and sorted through fluorescence and magnetic-based cell sorting...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38475822/the-scientific-rationale-and-study-protocol-for-the-dpp3-angiotensin-ii-and-renin-kinetics-in-sepsis-dark-sepsis-randomized-controlled-trial-serum-biomarkers-to-predict-response-to-angiotensin-ii-versus-standard-of-care-vasopressor-therapy-in-the-treatment
#28
JOURNAL ARTICLE
J Pedro Teixeira, David Perez Ingles, Jordan B Barton, James T Dean, Pablo Garcia, Susan J Kunkel, Preeyaporn Sarangarm, Natalie K Weiss, Christopher L Schaich, Laurence W Busse, Nathan D Nielsen
BACKGROUND: Data to support the use of specific vasopressors in septic shock are limited. Since angiotensin II (AT2) was approved by the Food and Drug Administration in 2017, multiple mechanistically distinct vasopressors are available to treat septic shock, but minimal data exist regarding which patients are most likely to benefit from each agent. Renin and dipeptidyl peptidase 3 (DPP3) are components of the renin-angiotensin-aldosterone system which have been shown to outperform lactate in predicting sepsis prognosis, and preliminary data suggest they could prove useful as biomarkers to guide AT2 use in septic shock...
March 12, 2024: Trials
https://read.qxmd.com/read/38474320/identification-of-key-molecular-pathways-and-associated-genes-as-targets-to-overcome-radiotherapy-resistance-using-a-combination-of-radiotherapy-and-immunotherapy-in-glioma-patients
#29
JOURNAL ARTICLE
Tianqi Zhang, Qiao Zhang, Xinwei He, Yuting Lu, Andrew Shao, Xiaoqiang Sun, Yongzhao Shao
Recent mechanistic studies have indicated that combinations of radiotherapy (RT) plus immunotherapy (via CSF-1R inhibition) can serve as a strategy to overcome RT resistance and improve the survival of glioma mice. Given the high mortality rate for glioma, including low-grade glioma (LGG) patients, it is of critical importance to investigate the mechanism of the combination of RT and immunotherapy and further translate the mechanism from mouse studies to improve survival of RT-treated human glioma patients...
March 6, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38431451/efficiency-of-the-technology-based-homecare-family-empow-for-children-with-cancer-and-their-parents-a-study-protocol-for-a-randomized-controlled-trial
#30
JOURNAL ARTICLE
Hazal Ozdemir Koyu, Ebru Kilicarslan
OBJECTIVES: Home-based pediatric cancer care requires addressing both physical and psychosocial care needs for children and their parents Currently, there is a notable gap in intervention programs that evaluate technology-based psychosocial empowerment for children and parents in home-based pediatric cancer care. The study protocol was to assess the efficiency of a technology-based psychosocial empowerment intervention for home-based care for children with cancer and their parents. METHODS: This study was planned as a single-blinded parallel-group randomized controlled experimental design...
March 1, 2024: Seminars in Oncology Nursing
https://read.qxmd.com/read/38422498/matrix-metalloproteinase-9-testing-of-golden-rice-cookies-with-piper-crocatum-active-extract-for-preventing-foot-ulcers-in-patients-with-diabetes-protocol-for-a-randomized-controlled-trial
#31
JOURNAL ARTICLE
Andina Setyawati, Ariyanti Saleh, Takdir Tahir, Saldy Yusuf, Syahrul Syahrul, Aminuddin Aminuddin, Muhammad Raihan, Nuurhidayat Jafar, Hasyrul Hamzah, Nur Arfian
BACKGROUND: Diabetic foot ulcers (DFUs) present a formidable challenge to both patients and health care systems. DFUs significantly reduce the quality of life for patients, prolong hospital stays, and are the cause of approximately 70,000 lower limb amputations across the globe annually. Prevention of DFUs primarily involves the optimization of blood sugar levels and the effective management of complications, particularly peripheral neuropathy. Golden Rice has been proven to lower blood sugar levels due to its beta-carotene content, and Piper crocatum (P...
February 29, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38417922/eggs-for-improving-nutrition-cognitive-development-and-reducing-linear-growth-retardation-among-infants-and-young-children-enrich-protocol-of-an-egg-supplementation-trial-among-children-aged-9-18-months-in-hyderabad-india
#32
JOURNAL ARTICLE
Santosh Kumar Banjara, Sai Ram Challa, Little Flower Augustine, Teena Dasi, Radhika Madhari, Sylvia Fernandez Rao, Ravindranadh Palika, Raghu Pullakhandam, Rajender Rao Kalashikam, Ramachandrappa Naveen Kumar, Dharani Pratyusha Palepu, Monica Chilumula, Kiruthika Selvaraj, Preethi Gopinath, Hilary Davies-Kershaw, Modou Lamin Jobarteh, Paul Haggarty, Claire Heffernan, Elaine Ferguson, Bharati Kulkarni
INTRODUCTION: Evidence on the impact of nutrient-rich animal source foods such as eggs for improving child growth and cognition is inconsistent. This study aims to examine the impact of an egg intervention in children, along with behaviour change communication (BCC) to the mother, on linear growth and cognition, and nutritional status in children aged 9-18 months. METHODS AND ANALYSIS: A 9-month open-labelled randomised controlled trial will be conducted in three urban slums in Hyderabad, India, as a substudy of an observational cohort study (n=350) following pregnant women and their children until 18 months of age in a population at risk of stunting...
February 27, 2024: BMJ Paediatrics Open
https://read.qxmd.com/read/38387741/orphan-gpr52-as-an-emerging-neurotherapeutic-target
#33
REVIEW
Saghir Ali, Pingyuan Wang, Ryan E Murphy, John A Allen, Jia Zhou
GPR52 is a highly conserved, brain-enriched, Gs/olf -coupled orphan G protein-coupled receptor (GPCR) that controls various cyclic AMP (cAMP)-dependent physiological and pathological processes. Stimulation of GPR52 activity might be beneficial for the treatment of schizophrenia, psychiatric disorders and other human neurological diseases, whereas inhibition of its activity might provide a potential therapeutic approach for Huntington's disease. Excitingly, HTL0048149 (HTL'149), an orally available GPR52 agonist, has been advanced into phase I human clinical trials for the treatment of schizophrenia...
February 20, 2024: Drug Discovery Today
https://read.qxmd.com/read/38380091/effects-of-dietary-d-lactate-levels-on-rumen-fermentation-microflora-and-metabolomics-of-beef-cattle
#34
JOURNAL ARTICLE
Qian Gao, Jianfu He, Jin Wang, Yonghui Yan, Lei Liu, Zuo Wang, Weijun Shen, Fachun Wan
INTRODUCTION: Excessive intake of lactate caused by improper use of silage in animal husbandry has adverse effects on rumen fermentation, such as rumen acidosis. The speed of absorption and metabolism of D -lactate in rumen epithelial cells was slower than that of L -lactate, making D -lactate more prone to accumulate and induce rumen acidosis. Therefore, this study was conducted to explore the effects of dietary D -lactate levels on rumen fermentation of beef cattle and its mechanism in an in vitro system...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38369029/a-quantitative-systems-pharmacology-workflow-towards-optimal-design-and-biomarker-stratification-of-atopic-dermatitis-clinical-trials
#35
JOURNAL ARTICLE
Natacha Go, Simon Arsène, Igor Faddeenkov, Théo Galland, Shiny Martis B, Diane Lefaudeux, Yishu Wang, Loic Etheve, Evgueni Jacob, Claudio Monteiro, Jim Bosley, Caterina Sansone, Christian Pasquali, Lorenz Lehr, Alexander Kulesza
BACKGROUND: The development of atopic dermatitis (AD) drugs is confronted by many disease phenotypes and trial design options, which are hard to explore experimentally. OBJECTIVE: Optimize AD trial design using simulations. METHODS: We constructed a quantitative systems pharmacology (QSP) model of AD and standard of care (SoC) treatments and generated a phenotypically diverse virtual population whose parameter distribution is a) derived from known relationships between AD biomarkers and disease severity and b) calibrated using disease severity evolution under SoC regimens...
February 16, 2024: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/38361138/developing-and-validating-a-model-of-humeral-stem-primary-stability-intended-for-in-silico-clinical-trials
#36
JOURNAL ARTICLE
Ghislain Maquer, Christine Mueri, Adam Henderson, Jeff Bischoff, Philippe Favre
In silico clinical trials (ISCT) can contribute to demonstrating a device's performance via credible computational models applied on virtual cohorts. Our purpose was to establish the credibility of a model for assessing the risk of humeral stem loosening in total shoulder arthroplasty, based on a twofold validation scheme involving both benchtop and clinical validation activities, for ISCT applications. A finite element model computing bone-implant micromotion (benchtop model) was quantitatively compared to a bone foam micromotion test (benchtop comparator) to ensure that the physics of the system was captured correctly...
February 15, 2024: Annals of Biomedical Engineering
https://read.qxmd.com/read/38345088/nutritional-interventions-for-preventing-and-treating-pressure-ulcers
#37
REVIEW
Gero Langer, Ching Shan Wan, Astrid Fink, Lukas Schwingshackl, Daniela Schoberer
BACKGROUND: Pressure ulcers are localized injuries to the skin or the underlying tissue, or both, and are common in older and immobile people, people with diabetes, vascular disease, or malnutrition, as well as those who require intensive or palliative care. People with pressure ulcers often suffer from severe pain and exhibit social avoidance behaviours. The prevention and treatment of pressure ulcers involves strategies to optimize hydration, circulation, and nutrition. Adequate nutrient intake can reduce the risk factor of malnutrition and promote wound healing in existing pressure ulcers...
February 12, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38336023/systemic-inflammation-and-risk-of-parkinson-s-disease-a-prospective-cohort-study-and-genetic-analysis
#38
JOURNAL ARTICLE
Chunyu Li, Bin Ke, Jianhai Chen, Yi Xiao, Shichan Wang, Rirui Jiang, Xiaoting Zheng, Junyu Lin, Jingxuan Huang, Huifang Shang
BACKGROUND: Multiple evidence has suggested the complex interplay between Parkinson's disease (PD) and systemic inflammation marked by C-reactive protein (CRP) and interleukin 6 (IL-6). Nevertheless, the findings across studies have shown inconsistency, and the direction of the effect remains controversial. Here, we aimed to explore the link between CRP and IL-6 and the risk of PD. METHODS: Based on data from the UK Biobank, we investigated the association between baseline CRP and IL-6 and the risk of incident PD with Cox proportional hazards regression analysis...
February 7, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38297878/optimal-design-for-inference-on-the-threshold-of-a-biomarker
#39
JOURNAL ARTICLE
Alessandro Baldi Antognini, Rosamarie Frieri, William F Rosenberger, Maroussa Zagoraiou
Enrichment designs with a continuous biomarker require the estimation of a threshold to determine the subpopulation benefitting from the treatment. This article provides the optimal allocation for inference in a two-stage enrichment design for treatment comparisons when a continuous biomarker is suspected to affect patient response. Several design criteria, associated with different trial objectives, are optimized under balanced or Neyman allocation and under equality of the first two empirical biomarker's moments...
January 31, 2024: Statistical Methods in Medical Research
https://read.qxmd.com/read/38297399/a-multimodal-precision-prevention-approach-combining-lifestyle-intervention-with-metformin-repurposing-to-prevent-cognitive-impairment-and-disability-the-met-finger-randomised-controlled-trial-protocol
#40
JOURNAL ARTICLE
Mariagnese Barbera, Jenni Lehtisalo, Dinithi Perera, Malin Aspö, Mary Cross, Celeste A De Jager Loots, Emanuela Falaschetti, Naomi Friel, José A Luchsinger, Hanna Malmberg Gavelin, Markku Peltonen, Geraint Price, Anna Stigsdotter Neely, Charlotta Thunborg, Jaakko Tuomilehto, Francesca Mangialasche, Lefkos Middleton, Tiia Ngandu, Alina Solomon, Miia Kivipelto
BACKGROUND: Combining multimodal lifestyle interventions and disease-modifying drugs (novel or repurposed) could provide novel precision approaches to prevent cognitive impairment. Metformin is a promising candidate in view of the well-established link between type 2 diabetes (T2D) and Alzheimer's Disease and emerging evidence of its potential neuro-protective effects (e.g. vascular, metabolic, anti-senescence). MET-FINGER aims to test a FINGER 2.0 multimodal intervention, combining an updated FINGER multidomain lifestyle intervention with metformin, where appropriate, in an APOE ε4-enriched population of older adults (60-79 years) at increased risk of dementia...
January 31, 2024: Alzheimer's Research & Therapy
keyword
keyword
82348
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.